Chronic myelogenous leukemia electrocardiogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[3]

Overview

There are no specific EKG findings in chronic myelogenous leukemia.

Electrocardiogram

There are no specific EKG findings in chronic myelogenous leukemia. However, EKG may be necessary for patients receiving nilotinib, as this can cause cardiac toxicity and peripheral vascular disease.^[1]

References

↑ Kim TD, le Coutre P, Schwarz M, Grille P, Levitin M, Fateh-Moghadam S; et al. (2012). “Clinical cardiac safety profile of nilotinib”. Haematologica. 97 (6): 883–9. doi:10.3324/haematol.2011.058776. PMC 3366654. PMID 22271904.

Template:WikiDoc Sources

[pmid22271904-1] Kim TD, le Coutre P, Schwarz M, Grille P, Levitin M, Fateh-Moghadam S; et al. (2012). “Clinical cardiac safety profile of nilotinib”. Haematologica. 97 (6): 883–9. doi:10.3324/haematol.2011.058776. PMC 3366654. PMID 22271904.

[1]